Amazon Enters India’s Booming Diagnostics Market, Intensifying Competition

India’s diagnostics market, projected to reach $20 billion by 2026, is witnessing fierce competition as major players like Adani (Adani Health Ventures), Reliance (Reliance Life Sciences), and Tata (1mg) entered the space in 2022. The sector has also seen strategic moves from pharma majors and traditional diagnostic firms—PharmEasy acquired

for ₹4,546 crore in 2021, while Dr. Lal PathLabs ( ) continues to expand through acquisitions. Now, Amazon India has joined the race with its new at-home diagnostics service, Amazon Diagnostics , launched in collaboration with Orange Health Labs. Available in six cities, it offers over 1,000 tests with doorstep sample collection and digital reports within six hours. This move marks Amazon’s third healthcare offering after Amazon Clinic and Amazon Pharmacy, which have already seen strong growth. With a focus on convenience, price parity, and customer experience, Amazon aims to strengthen its position in India’s fast-evolving healthcare ecosystem. As more tech-driven players enter and consolidate the market, the diagnostics sector is set for rapid transformation, driven by rising health awareness, digital adoption, and demand for accessible, affordable services.